RxDoctor Payments Data

Brook Hager, DO

Family Medicine · Conway, SCNPI 1679100879

Payments from drug & device makers

$612in general payments, 2019–2025

Across 26 payments — averaging $23.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$168
  • Lilly USA, LLC$143
  • Novo Nordisk$139
  • AbbVie$86
  • Amgen$29
  • Pfizer$17
  • plus $30 from 2 others

What the payments were for

  • Food & beverage$612100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$612 in reported general payments places this provider in the 50th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$31,426
Medicare patients
214
Services billed
333

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$34,113
MounjaroTirzepatide18$20,433
Albuterol Sulfate HfaAlbuterol Sulfate47$946
Atorvastatin Calcium100$657
Gabapentin21$523
Rosuvastatin Calcium24$519
Metoprolol Succinate29$403
Omeprazole30$344
Levothyroxine Sodium56$310
Losartan Potassium35$304
Lisinopril36$261
Amlodipine Besylate57$243
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid16$234
Pantoprazole Sodium29$203
ClopidogrelClopidogrel Bisulfate14$201

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$139$34,11336 claims
Lilly USA, LLCMounjaro$143$20,43318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Conway

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →